Septic arthritis caused by Mycobacterium kansasii in a prosthetic knee joint

Journal of Clinical Microbiology

Volumn 44, Issue 7, 2006, Pages 2648-2649

  Neuberger, A ^a   Sprecher, H ^a   Oren, I ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CAPREOMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ACID FAST BACTERIUM; AGED; ANEMIA; ARTHRODESIS; ARTICLE; BACTERIAL ARTHRITIS; BACTERIAL GENE; CASE REPORT; ERYTHEMA; ERYTHROCYTE SEDIMENTATION RATE; HSP65 GENE; HUMAN; HYPOALBUMINEMIA; JOINT SWELLING; KNEE ARTHROSCOPY; KNEE PAIN; MALE; MONARTHRITIS; MYCOBACTERIUM KANSASII; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THROMBOCYTOSIS; TOTAL KNEE REPLACEMENT;

AGED, 80 AND OVER; ARTHRITIS, INFECTIOUS; HUMANS; KNEE PROSTHESIS; MALE; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM KANSASII; PROSTHESIS-RELATED INFECTIONS;

MYCOBACTERIUM KANSASII;

EID: 33746191660     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00087-06     Document Type: Article

References (10)

1. Bailey, R. K., S. Wyles, M. Dingley, F. Hesse, and G. W. Kent. 1970. The isolation of high catalase Mycobacterium kansasii from tap water. Am. Rev. Respir. Dis. 101:430-431.
2. Bernard, L., V. Vincenet, O. Lortholary, L. Raskine, C. Vettier, D. Colaitis, D. Mechali, F. Bricaire, E. Bouvet, B. F. Sadr, V. Lalande, C. Perronne, and Groupe d'étude sur l'ostéite. 1999. Mycobacterium kansasii septic arthritis: French retrospective study of 5 years and review. Clin. Infect. Dis. 29:1455-1460.
3. Devallois, A., K. S. Goh, and N. Rastogi. 1997. Rapid identification of mycobacteria to species level by PCR-restriction fragment length polymorphism analysis of the hsp65 gene and proposition of an algorithm to differentiate 34 mycobacterial species. J. Clin. Microbiol. 35:2969-2973.
4. Griffith, D. E., B. A. Brown-Elliot, and R. J. Wallace, Jr. 2003. Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study. Clin. Infect. Dis. 37:1178-1182.
5. Herold, R. C., P. A. Lotke, and R. R. MacGregor. 1987. Prosthetic joint infections secondary to rapidly growing Mycobacterium fortuitum. Clin. Orthop. Relat. Res. 216:183-186.
6. Lillo, M., S. Orengo, P. Cernoch, and R. L. Harris. 1990. Pulmonary and disseminated infection due to Mycobacterium kansasii: a decade of experience. Rev. Infect. Dis. 12:760-767.
7. Spinner, R. J., D. J. Sexton, R. D. Goldner, and L. S. Levin. 1996. Periprosthetic infections due to Mycobacterium tuberculosis in patients with no prior history of tuberculosis. J. Arthroplasty 11:217-222.
8. Tokumoto, J. I., S. E. Follansbee, and R. A. Jacobs. 1995. Prosthetic joint infection due to Mycobacterium tuberculosis: report of three cases. Clin. Infect. Dis. 21:134-136.
9. Witzig, R. S., B. A. Fazal, R. M. Mera, D. M. Mushatt, P. M. Dejace, D. L. Greer, and N. E. Hyslop, Jr. 1995. Clinical manifestations and implications of coinfection with Mycobacterium kansasii and human immunodeficiency virus type 1. Clin. Infect. Dis. 21:77-85.
10. Zimmetli, W., A. Trampus, and P. E. Ochsner. 2004. Prosthetic-joint infections. N. Engl. J. Med. 351:1645-1654.